Solid Biosciences SLDB
NASDAQ SLDB
$6.47 +0.07 (+1.17%)
As of: Oct 21, 2026 · 11:41 AM EDT

Solid Biosciences (SLDB) Asset Utilization Ratio (2021 - 2023)

Updated

Solid Biosciences' Asset Utilization Ratio was 0.03 in Q2 2023, down 4.2% from 0.03 a year earlier.

Analysis

Solid Biosciences (SLDB) Asset Utilization Ratio (2021 - 2023) Analysis & Trends

From Q2 2022 onward, Solid Biosciences has reported Asset Utilization Ratio for 4 quarters.

  • In earlier years, Asset Utilization Ratio was 0.07 in FY2021.
  • Quarterly Asset Utilization Ratio has moved between 0.03 (Q4 2022) and 0.03 (Q3 2022) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 0.62
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 0.49
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 0.47
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 0.52
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 0.46
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 0.51
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 0.40
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 0.58
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 0.31
10 Solid Biosciences 931.82 Mn -250.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 0.03
Dec 31, 2022 0.03
Sep 30, 2022 0.03
Jun 30, 2022 0.03
Jun 30, 2021 0.00
Mar 31, 2021 0.00
API Access

Solid Biosciences Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=SLDB&period=max&api_key=YOUR_API_KEY